Citation Impact
Citing Papers
Chromosome Abnormalities and Genetic Counseling
2011
Use of a decision aid for prenatal testing of fetal abnormalities to improve women’s informed decision making: a cluster randomised controlled trial [ISRCTN22532458]
2008
Early skin-to-skin contact for mothers and their healthy newborn infants
2016 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Randomised comparisons of medical tests: sometimes invalid, not always efficient
2000
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Peptide Signaling in Human Placenta and Membranes: Autocrine, Paracrine, and Endocrine Mechanisms*
1996
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
2008 Standout
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
2008 Standout
An evaluation of the decision‐making process regarding amniocentesis following a screen‐positive maternal serum screen result
2009
Progressive Statistics for Studies in Sports Medicine and Exercise Science
2008 Standout
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Applying decision analysis to facilitate informed decision making about prenatal diagnosis for Down syndrome: a randomised controlled trial
2004
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Fetoplacental histology as a predictor of karyotype: A controlled study of spontaneous first trimester abortions
1995
The variability of female reproductive ageing
2002
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
2010 Standout
Down's syndrome: The effects of prenatal diagnosis and demographic factors in a region of the eastern part of Germany
2000
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Gene Pathways That Delay Caenorhabditis elegans Reproductive Senescence
2014 StandoutNobel
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
2010 Standout
FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME
2001
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
2013 Standout
Down's syndrome
2003 Standout
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Effect size measures for mediation models: Quantitative strategies for communicating indirect effects.
2011 Standout
What Is the Role of Informal Healthcare Providers in Developing Countries? A Systematic Review
2013
Health Supervision for Children With Down Syndrome
2011 Standout
Effect size, confidence interval and statistical significance: a practical guide for biologists
2007 Standout
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
2009 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
2008 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Nicotine replacement therapy for smoking cessation
2012 Standout
Placental and Fetal Membrane Nephrin and Neph1 Gene Expression: Response to Inflammation
2005
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
2010 Standout
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Physical Activity, Fitness, Cognitive Function, and Academic Achievement in Children
2016 Standout
POLYPLOID INCIDENCE AND EVOLUTION
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Attitudes towards Down's syndrome: follow up of a cohort of 280 cases.
1995
The impact of training informal health care providers in India: A randomized controlled trial
2016 StandoutScienceNobel
Improving the Reporting Quality of Nonrandomized Evaluations of Behavioral and Public Health Interventions: The TREND Statement
2004 Standout
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
2009 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
2010 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of A. Mantingh being referenced
Women's opinions on the offer and use of prenatal diagnosis
1991
Trends in live birth prevalence of Down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis
2000
Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term
1997
Women's opinions on the offer and use of maternal serum screening
1993
Second‐trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome
1992
How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy
2000
The influence of serum screening on the amniocentesis rate in women of advanced maternal age
1994
Alpha‐fetoprotein in fetal serum, amniotic fluid, and maternal serum
1991
Skilled or Traditional Birth Attendant? Choices of Communities in Lukulu District, Rural Zambia
2008
Early recurrent miscarriage: histology of conception products
1990
First-trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Dutch Working Party on Prenatal Diagnosis.
1994
Schwangerschafts protein 1 (SP1) adds little to the age-related detection of fetal Down syndrome in the first trimester of pregnancy
1998
Randomised Controlled Trial of Magnetic-Resonance Pelvimetry in Breech Presentation at Term
1998